company

BIO8 AS

0254 OSLO

Return on Equity
11,45 %
Current Ratio
26,5
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue32 000
Net Income93 000
Total Assets818 000
Total Equity812 000
Income (NOK)2022
Revenue32 000
Expenditure−11 000
Operating Profit43 000
Financial Income54 000
Financial Costs0
Financial Balance54 000
Earnings Before Tax97 000
Tax4 000
Net Income93 000
Balance (NOK)2022
Total Fixed Assets658 000
Total Current Assets159 000
Total Assets818 000
Total Retained Equity704 000
Total Equity812 000
Total Long-Term Debt0
Total Current Debt6 000
Total Equity and Debt818 000
Cash flow (NOK)2022
Sales Income32 000
Other Income0
Revenue32 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure−11 000
Operating Profit43 000
Financial Income54 000
Financial Costs0
Financial Balance54 000
Dividends0
Net Income93 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets658 000
Total Fixed Assets658 000
Stock0
Total Investments0
Cash, Bank140 000
Total Current Assets159 000
Total Assets818 000
Total Equity812 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes2 000
Dividends0
Other Current Debt0
Total Current Debt6 000
Total Equity and Debt818 000
Financial indicators2022
Return on Equity11,45 %
Debt-to-Equity Ratio0
Operating Profit Margin134,38 %
Current Ratio26,5
Quick Ratio26,5
Equity Ratio0,99
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English